Millenia Hope To Acquire Cutting-Edge Bio-Pharma Technology

WILMINGTON, Del., Feb. 14 /PRNewswire-FirstCall/ -- Millenia Hope Inc. , a Bio-Pharma Corporation, is pleased to announce that through its Canadian subsidiary, Millenia Hope Bio-Pharma, it is in the process of acquiring assets and expertise of a cutting-edge Canadian Bio-Pharma firm. This acquisition will both broaden and deepen Millenia Hope's ability to improve the efficacy of its flagship product MMH Malarex(TM)/MMH 18(TM) and bring new, innovative products to market.

Simultaneously, this acquisition will give the company access to a unique technology platform in phytomics, in great demand internationally by multi- national cosmetic and pharmaceutical corporations. The outsourcing of laboratory research is a multi-billion dollar business annually and Millenia will be firmly entrenched in this lucrative market with its new acquisition.

About Millenia Hope:

Millenia Hope develops innovative treatments and quality products that will increase the quality of life, provide tools in the fight against diseases, and promote healthier lives. Our team is committed to research and development to deliver on global medical needs and to bring hope through healthcare solutions.

Safe Harbor Statement:

Certain statements made in this release may contain language describing the plans, goals, strategies, intentions, forecasts and expectations of Millenia Hope that may be referred to as "forward-looking statements." Several important factors could cause actual results to differ materially from those in such forward-looking statements, and Millenia Hope could encounter unanticipated obstacles and delays in developing products, services and markets.

For more information: Please contact: Mr. Hugo Valente, CFO Tel.: 514-846-5757 or 514-288-8822 http://www.milleniahope.comadmin@milleniahope.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

Millenia Hope Inc.

CONTACT: Mr. Hugo Valente, CFO, Millenia Hope Inc., +1-514-846-5757 or+1-514-288-8822, admin@milleniahope.com

Back to news